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SOLVING THE PROBLEM OF ORGAN DONATION
SHORTAGE
Nicole Saitta-Gill and Samuel D. Hodge, Jr.*
ABSTRACT
Organ donation, a medically perfected procedure, affords a second
chance at life for many people. Unfortunately, organ transplantation
demonstrates the stark reality of supply and demand. Thousands of
individuals are added to the transplant list each day, but many more
die during the same time frame waiting for new organs.1 The
solution to this dilemma seems simple: increase the supply. This
article will discuss several ways to achieve this goal. First, through
the HIV Organ Policy Equity Act, which allows for HIV-positive-toHIV-positive transplants,2 more transplantable organs will hopefully
be available in the future. Second, the supply of organs may increase
by changing the standards of organ donation from irreversible loss of
brain function to irreversible loss of cardiac function.3 Third,
educating individuals, especially minorities, about donation and the
regionally based system for transplants may result in a larger number
of matching donors and a greater number of potential recipients on
multiple transplant lists. Finally, efforts such as payments and
advertising for organs, giving priority transplants to registered
*

1.
2.
3.

Samuel D. Hodge, Jr., Esquire, a skilled litigator, is a professor of Legal Studies at
Temple University where he teaches both law and anatomy. He has authored more
than 150 articles in medical and legal journals and has written five medical/legal texts.
Professor Hodge is also considered one of the most popular CLE speakers in the
country, enjoys an AV Preeminent rating and has been named a top rated lawyer in
Pennsylvania. Nicole Marie Saitta-Gill is an associate at Stradley Ronon Stevens &
Young, LLP. She is a recent graduate of Temple University’s Beasley School of Law
and a former teaching assistant for Professor Hodge. She received an M.A. in English
Literature from Villanova University. An experienced academic researcher with a
background in pre-medical studies, she is particularly interested in research pertaining
to the intersection of law and medicine.
U.S. Dep’t of Health and Human Servs., The Need Is Real: Data, ORGANDONOR.GOV,
http://www.organdonor.gov/about/data.html (last visited Nov. 13, 2015).
42 U.S.C. § 274 (2012).
Jane Brody, The Solvable Problem of Organ Shortages, N.Y. TIMES (Aug. 28, 2007),
http://www.nytimes.com/2007/08/28/health/28brod.html?_r=1&.
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donors, and even confronting the disparate number of elderly donors
whose organs are never transplanted, may result in an increase in the
organ supply.
INTRODUCTION
Organ donation4 affords a second chance at life for many people.5
It is also one of the most extraordinary gifts a human can give
another since it can literally mean the difference between life and
death. Unfortunately, organ transplantation classically demonstrates
the stark reality of supply and demand.6 Thousands of individuals are
added to the transplant list each year,7 and on average, twenty-two
4.

5.

6.
7.

Organ donation is defined as “the surgical process of providing one or more organs to
be used for transplantation into another person. Organ donors can be deceased or
living.”
U.S. Dep’t of Health and Human Servs., Organ Donation and
Transplantation Saves Lives, ORGANDONOR.GOV, http://www.organdonor.gov/about/in
dex.html (last visited Nov. 13, 2015). A brief legal history of organ donation is as
follows: The National Conference of Commissioners of Uniform Acts (NCCUA)
“issued the Uniform Anatomical Gift Act (UAGA) in 1968, which was adopted . . . by
all fifty states.” Brendan Abel, Physician Assisted Homicide in Organ Donations
After Cardiac Death: The Failure of Biotechnologies to Comply with the Uniform
Definition of Death Act and the Dead Donor Rule, 7 J. HEALTH & BIOMEDICAL L. 573,
581 (2012) (internal quotation marks omitted). Congress passed two additional acts in
the 1980s. The National Organ Transplant Act (NOTA) of 1984 “prohibited the sale
of organs and tissues and ordered the Department of Health and Human Services
(DOHHS) to establish the Organ Procurement Transplant Network (OPTN) . . . for
organ matching.” Id. at 588 (internal quotation marks omitted). “The NCCUA [also]
revised the UAGA in 1987; however, only twenty-one states adopted the revision. . . .
Both iterations of the UAGA adopt the opt-in theory for solid organ donations . . . .”
Id. at 582. Adding Section Four to the 1987 UAGA “authorized coroners, medical
examiners, and public health officials to remove designated body parts, such as
corneas, without consent for transplantation if several conditions were met.” Id.
U.S. Dep’t of Health and Human Servs., Becoming a Donor, ORGANDONOR.GOV,
http://www.organdonor.gov/becomingdonor/index.html?gclid=CIav9JukvsMCFUkvg
QodI1gAyQ (last visited Nov. 13, 2015). The concept of organ transplantation is not
new to medicine. History shows that in the third century A.D., a physician in China
discussed organ transplants. Medicine has now progressed beyond the days of mere
conceptualization of the process to the point where organ transplantation is an
ordinary medical procedure. In addition to organs, such as livers and hearts, doctors
have transplanted hands and even a face. See Robert John Kane & Lawrence E.
Singer, Organ and Tissue Transplantation-Anatomical Gifts, 22 ILL. PRAC., THE LAW
OF MEDICAL PRACTICE IN ILLINOIS § 33:1 (3d ed.).
Melissa Wong, Coverage for Kidneys: The Intersection of Insurance and Organ
Transplantation, 16 CONN. INS. L.J. 535, 535 (2010).
See Data, UNITED NETWORK FOR ORGAN SHARING, https://www.unos.org/data/ (last
visited Nov. 13, 2015). As of 9:37 AM on September 14, 2015, 122,532 individuals
were on the list for a transplant. While 15,083 transplants occurred between January
and June of 2015, these organs came from only 7323 donors. Id.
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people die every twenty-four hours waiting for new organs.8 The
easiest way to solve the problem of transplant shortages seems
simple: increase the supply.9 But how can this seemingly simple goal
be achieved? First, through the HIV Organ Policy Equity Act, which
allows for HIV-positive-to-HIV-positive transplants, more
transplantable organs will hopefully be available in the future. 10
Second, the supply of organs may increase by changing the standards
of organ donation from irreversible loss of brain function to
Educating individuals,
irreversible loss of cardiac function.11
especially minorities, about donation and the regionally based system
for transplants may result in a larger number of matching donors and
a greater number of potential recipients on multiple transplant lists.12
And other suggestions, such as payments and advertising for organs,
giving priority transplants to registered donors, and even confronting
8.
9.

10.

11.

12.

U.S. Dep’t of Health and Human Servs., supra note 1.
Transplants are relatively routine in medical practice and the success rate is fairly
high. Nevertheless, it is not without risk and some of the major dangers include: “1)
blood and tissue incompatibility between the patient and the donor; 2) ineffective
treatment to restrict the patient’s own immune system from ‘attacking’ the
transplanted organ; and 3) deterioration of the organ caused by a lack of oxygenated
blood, known as ischemia.” Abel, supra note 4, at 575.
A major issue in transplants is the cost and whether health insurance will pay for it.
Congress has attempted to regulate this problem under Medicaid by making sure
states apply their coverage decisions in a uniform and fair fashion. As noted in Ellis
v. Paterson:
To assure that State coverage decisions for organ transplants are
based on clear principles consistently applied, and not on political
or media considerations, section 9507 of the Consolidated
Omnibus Budget Reconciliation Act of 1985 (COBRA), P.L. 99272, requires that a State which
covers
organ
transplant
procedures set forth under its Medicaid plan written standards
respecting the coverage of such procedures. Under these
standards, similarly situated individuals must be treated alike.
Ellis v. Patterson, 859 F.2d 52, 55 (8th Cir. 1988) (emphasis omitted) (quoting H.R.
Rep. No. 100-391, pt. 1, at 532 (1987), reprinted in 1987 U.S.C.C.A.N. 2313-1, 2313352). Nevertheless, while Congress may establish guidelines and standards to
guarantee state obedience with the Medicaid laws, it is still the obligation of the states
to create coverage criteria “subject to federal approval and reimbursement.” Wong,
supra note 6, at 546.
See Maxine M. Harrington, The Thin Flat Line: Redefining Who Is Legally Dead in
Organ Donation After Cardiac Death, 86 DENV. U. L. REV. 335, 337 (2009)
(explaining the benefits of donations after “cardiac death” rather than “brain death”).
Kimberly D. Krawiec & Michael A. Rees, Reverse Transplant Tourism, 77 L. &
CONTEMP. PROBS. 145, 172 (2014); see also Ingrid Kinkopf-Zajac, Assessing Patient
Compliance in the Selection of Organ Transplant Recipients, 6 HEALTH MATRIX 503,
503 (1996).
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the disparate number of elderly donors whose organs are never
transplanted, may result in an increase in the organ supply.13
I.

INCREASING THE SUPPLY THROUGH HIV-POSITIVE
TRANSPLANTS

Many HIV-positive patients are on a transplant waiting list, waiting
for a kidney or liver.14 What if the wait is too long? What if the
person dies before receiving the life-saving organ? Would you be
appalled if you discovered that a matching donor kidney could have
been transplanted, but it was discarded after testing positive for
HIV?15 This scenario is more real than you think. For many years,
HIV patients were banned from donating organs because of the
uncertainty as to what caused the disease.16 Fortunately, with the
signing of the HIV Organ Policy Equity Act, HIV-positive
individuals can now obtain transplants from HIV-positive donors.17
13.

14.

15.

16.

17.

See generally Paul P. Lee, The Organ Supply Dilemma: Acute Responses to a Chronic
Shortage, 20 COLUM. J.L. & SOC. PROBS. 363 (1986) (discussing the possible increase
in available donative organs through payment and priority systems).
Many HIV-positive individuals suffer from kidney and renal disease. Michele
Roland, Safety and Efficacy of Solid Organ Transplantation in HIV-Positive Patients,
PHYSICIANS’ RES. NETWORK (2001), http://www.prn.org/images/pdfs/503_roland_v6n
1.pdf.
There are a variety of laws that require donors to be tested for HIV prior to the
transplantation of their organs. However, Montana takes an interesting approach and
will allow a transplant without HIV testing in an emergency. Its law states:
Prior to donation of an organ, semen, or tissues, HIV diagnostic
testing of a prospective donor, in accordance with nationally
accepted standards adopted by the department by rule, is required
unless the transplantation of an indispensable organ is necessary
to save a patient’s life and there is not sufficient time to perform
an HIV diagnostic test.
MONT. CODE ANN. § 50-16-1008(1) (2013); accord 20 ILL. COMP. STAT. ANN.
2310/2310–330 (West 2007).
Could HIV-Infected Organs Save Lives?, JOHNS HOPKINS MED. (Mar. 30, 2011),
http://www.hopkinsmedicine.org/news/media/releases/could_hiv_infected_organs_sa
ve_lives.
Such a transplant would clearly have to come with a full disclosure of the fact that the
organ is coming from a person infected with HIV to avoid a malpractice claim. For
instance, in a case in which the names of the parties have been withheld, the decedent
obtained a kidney from a donor with brain cancer. While this type of transplant is
allowed, the decedent also developed a malignant glioblastoma. In a malpractice suit
against the transplant surgeon, it was alleged that the decedent should have been told
that the transplanted organ was donated by a person with cancer. The case was settled
for $750,000. 24 NEW ENG. JURY VERDICT REV. & ANALYSIS, 2007, at 1:C3, 2007
WL 8026533 (Mass.); cf. Kelly v. Fenton, No. 08-33833, 2012 WL 1359760, slip op.
30878(U) (N.Y. Sup. Ct. Mar. 30, 2012).
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A. A Background on HIV: How It Is Different From AIDS
The Center for Disease Control (CDC) estimates that over 1.2
million people aged thirteen years and older are living with HIV,
including over 156,300 who are unaware they are affected.18 About
50,000 people become infected with HIV each year, and in 2010,
there were around 47,500 new HIV infections in the United States
alone.19 In 2013, the estimated number of persons diagnosed with
AIDS in the United States was 26,6888.20 But, while the acronyms
“AIDS” and “HIV” are commonplace in today’s jargon, many
individuals remain unaware of the difference between the two terms
or do not fully understand what they mean.
HIV stands for “Human Immunodeficiency Virus” and is similar to
other pervasive viruses, such as the flu.21 However, while the body
uses its immune system to rid itself of the flu, it cannot rid itself of
HIV.22 In fact, HIV attacks key cells that are part of the immune
system, using them to multiply before destroying them.23 When the
body can no longer fight infections and disease because of a
depletion of immune system cells, the final stage of the HIV
infection, known as AIDS, occurs.24
AIDS stands for “Acquired Immune Deficiency Syndrome,” and a
person is characterized as having AIDS once he has “less than 200
CD4 cells” (also known as “T-helper” cells which are a critical part
of one’s immune system) “or if [his] CD4 percentage is less than
14% percent.”25 A patient is also diagnosed as having AIDS when he
develops an opportunistic infection, such as pneumonia, skin cancer,
a particular eye infection, or a fungal infection that can cause
thrush.26 Globally, in 2014, 1.2 million people died of AIDS-related

18.
19.
20.
21.
22.
23.
24.
25.
26.

HIV in the United States: At a Glance, CTRS. FOR DISEASE CONTROL & PREVENTION,
http://www.cdc.gov/hiv/statistics/basics/ataglance.html (last updated July 1, 2015).
Basic Statistics, CTRS. FOR DISEASE CONTROL & PREVENTION,
http://www.cdc.gov/hiv/basics/statistics.html (last updated Sept. 29, 2015).
Statistics Overview, CTRS. FOR DISEASE CONTROL & PREVENTION,
http://www.cdc.gov/hiv/statistics/basics/ (last updated Sept. 11, 2015).
What is HIV/AIDS?, AIDS.GOV, https://www.aids.gov/hiv-aids-basics/hiv-aids101/what-is-hiv-aids/ (last updated Apr. 29, 2014).
Id.
Id.
Id.
Int’l Assoc. of Providers of AIDS Care, What Is AIDS?, AIDS INFONET (Jan. 24,
2014), http://www.aidsinfonet.org/uploaded/factsheets/180_eng_101.pdf.
Id.
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causes.27 It is important to note, however, that “not everyone who has
HIV progresses to AIDS,” and, especially with advances in treatment,
individuals infected with HIV “can have a nearly normal life
expectancy.”28 It is this population, those living with HIV that has
not progressed to AIDS, that the HIV Organ Policy Equity Act
targets.
B. History Surrounding Positive-Positive Transplants
The HIV Organ Policy Equity (HOPE) Act, signed in November
2013, updates regulations that were well out of date.29 The National
Organ Transplant Act, enacted in 1984, and a particular 1988
amendment to this Act, prohibited donations of HIV-infected
organs.30 This ban was enacted around the same time as bans
prohibiting people with HIV from donating blood and stemmed from
a belief that “organs should go to people with a better chance of
survival.”31 Thus, attitudes surrounding the 1988 amendment
reflected the pervasive bias against HIV-infected patients, whether
they be donors or recipients.32
In 1994, the CDC’s “Guidelines for Preventing Transmission of
Human Immunodeficiency Virus [HIV] Through Transplantation of
Human Tissue and Organs” provided that “[r]egardless of their HIV
antibody test results,33 persons who meet any of the criteria listed
27.
28.
29.

30.
31.

32.

33.

HIV/AIDS, WORLD HEALTH ORG., http://www.who.int/features/qa/71/en/ (last updated
July 2015).
What Is HIV/AIDS?, supra note 21.
Brian Krans, HIV Organ Donation Gives Hope to Thousands of Patients,
HEALTHLINENEWS (Dec. 1, 2013), http://www.healthline.com/health-news/hiv-organdonation-will-save-thousands-of-lives-120113.
Id.
Ending HIV Organ Donation Ban Could Eliminate Transplant Waiting List for People
with HIV, AIDSMEDS (Mar. 30, 2011), http://www.aidsmeds.com/articles/hiv_transp
lant_organ_1667_20165.shtml [hereinafter Ending HIV Organ Donation Ban].
Id. A 1998 study revealed that the vast majority of surveyed clinics “would not
transplant a kidney from a cadaveric (88%) or a living donor (91%) into an
asymptomatic HIV-infected patient who is otherwise a good candidate for
transplantation.” Roland, supra note 14.
Although different types of antibody tests may be used for HIV screening, “[a]ll HIV
tests used in the U.S. detect HIV-1,” the most common form of HIV in the United
States, and “some tests have been developed that can also detect HIV-2. Am. Ass’n.
for Clinical Chemistry, HIV Antibody, LAB TESTS ONLINE, http://labtestsonline.org/un
derstanding/analytes/hiv-antibody/tab/test/ (last modified Feb. 24, 2015). These
“[c]ombination tests . . . detect the HIV antibody and the HIV antigen called the p24
antigen,” which is typically high in the beginning stages of the infection. Id. There
are several different methods of testing, including a blood or oral sample obtained by
one’s doctor, or an at-home collection kit. Id.

2015

Solving the Organ Donation Shortage

35

below should be excluded from donation of organs or tissues unless
the risk to the recipient of not performing the transplant is deemed to
be greater than the risk of HIV transmission and disease . . . .”34
Behaviors included “[m]en who have had sex with another man in the
preceding 5 years.”35 In 1996, the CDC became a little more liberal
with its restrictions, stating “transplant teams are encouraged to
accept and transplant organs from medically appropriate donors who
test HIV-antibody negative but have behavioral risk criteria for HIV
infection after the transplant teams have discussed the risks and
benefits with potential recipients and/or their families.”36
However, as scientific developments in HIV treatment grew, so too
did the clamoring to reverse the longtime ban on HIV-infected organ
donation. With the success of active antiretroviral therapy,37 fewer
people are dying of AIDS-related complications today.38 Instead,
more individuals are now dying of disease processes, including endstage liver and renal diseases.39 This recent trend led to a 2011 study
conducted by Johns Hopkins University School of Medicine,
published in the American Journal of Transplantation.40 The study
sought to address the dilemma of having needy HIV-positive
recipients who could not receive transplants from willing HIVpositive potential donors.41 Pulling data from the Nationwide
34.

35.
36.
37.

38.

39.
40.

41.

Doe v. Univ. of Chi. Med. Ctr., 20 N.E.3d 1, 3 (Ill. App. Ct. 2014) (emphasis added)
(quoting Martha F. Rogers et al., Ctrs. for Disease Control & Prevention, Guidelines
for Preventing Transmission of Human Immunodeficiency Virus Through
Transplantation of Human Tissue and Organs, 43 MORBIDITY & MORTALITY WKLY.
REP., May 20, 1994, at 12, http://stacks.cdc.gov/view/cdc/13462 [hereinafter CDC
Guidelines]).
Id. (alteration in original) (quoting CDC Guidelines, supra note 34).
Id. (quoting Clarification of Human Immunodeficiency Virus Screening Practices for
Organ Donors, 61 Fed. Reg. 56,548, 56,549 (Nov. 1, 1996)).
“Antiretroviral therapy (ART) is the combination of antiretroviral medicines used to
slow the rate at which HIV [multiplies] in the body.” ART aims to reduce the amount
of virus in an individual’s body. HIV: Antiretroviral Therapy (ART) - Topic
Overview, WEBMD.COM, http://www.webmd.com/hiv-aids/tc/hiv-highly-activeantiretroviral-therapy-haart-topic-overview (last visited Nov. 13, 2015) [hereinafter
ART - Topic Overview].
See UNAIDS, AIDS by the Numbers, at 4, U.N. Doc. JC2571/1/E (2013),
http://www.unaids.org/sites/default/files/media_asset/JC2571_AIDS_by_the_numbers
_en_1.pdf; see also Roland, supra note 14; ART - Topic Overview, supra note 37.
Roland, supra note 14.
See B. J. Boyarsky et al., Estimating the Potential Pool of HIV-Infected Deceased
Organ Donors in the United States, 11 AM. J. TRANSPLANTATION 1209, 1209–10
(2011), http://onlinelibrary.wiley.com/doi/10.1111/j.1600-6143.2011.03506.x/epdf;
see also Ending HIV Organ Donation Ban, supra note 31.
See Boyarsky et al., supra note 40; Ending HIV Organ Donation Ban, supra note 31.
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Inpatient Study and the HIV Research Network, the Johns Hopkins
team estimated the number of deaths by HIV-positive people “where
viable organs might have been available for transplantation.”42 The
number of deaths in this category totaled “534 each year between
2005 and 2008 in the Nationwide Inpatient Study and . . . 494 each
year between 2000 and 2008 in the HIV Research Network.”43
Translated, this information means that “500 HIV-infected patients
would be eligible for life-saving transplants each year if the ban was
overturned, and allowing those transplants would shorten wait times
for non-HIV infected patients.”44 Based upon this study, the
American Society of Transplant Surgeons, American Society of
Transplantation, Association of Organ Procurement Organizations,
and the United Network for Organ Sharing started to urge lawmakers
to overturn the ban, releasing a joint statement on the issue in 2011.45
It was this background that eventually led lawmakers to enact the
HOPE Act.
While the thought of transplanting HIV-infected organs is
revolutionary for the United States, other countries have already
pioneered HIV-positive-to-HIV-positive kidney transplants.46 Since
2008, Dr. Elmi Muller, a transplant surgeon in Cape Town, South
Africa, has conducted at least 26 such transplants.47 Of these
transplants, only two have failed as of November 2013.48 While most
donations have been from cadavers, the first transplant between a
living HIV-positive donor and recipient recently occurred in Tel Aviv
with great success.49 The doctors in Israel stated that “due to much
experience in South Africa with kidney and even liver donations from

42.
43.
44.

45.

46.

47.
48.
49.

Ending HIV Donation Ban, supra note 31.
Id.
Nicole Jones, Hopkins Researchers Help Overturn Government Ban, WMAR BALT.
(Nov. 21, 2013, 11:16 PM), http://www.abc2news.com/news/health/johns-hopkinsresearchers-help-overturn-government-ban.
Angela Townsend, Should the Ban on HIV-Positive Organ Transplants Be Lifted?
CLEVELAND.COM (Sept. 12, 2011, 6:00 PM), http://www.cleveland.com/healthfit/inde
x.ssf/2011/09/should_the_ban_on_hiv-positive.html.
See Sara Reardon, United States to Allow Transplants of HIV-Infected Organs,
NATURE.COM (Nov. 13, 2013), http://www.nature.com/news/united-states-to-allowtransplants-of-hiv-infected-organs-1.14170.
Id.
Id.
Judy Siegel-Itzkovich, Sourasky Announces World’s First Kidney Donation,
Transplant Between Live HIV Carriers, JERUSALEM POST (Aug. 15, 2013, 6:45 PM),
http://www.jpost.com/Health-and-Science/Worlds-first-live-kidney-donation-by-HIVcarrier-and-transplant-into-another-carrier-announced-by-Tel-Aviv-SouraskyMedical-Center-323225.
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brain-dead patients to HIV patients, the success rate of transplants
has risen to be almost equal to those of non-carriers.”50
So why would countries such as South Africa or Israel trump the
United States in terms of its progressive view on HIV-positive-toHIV-positive transplants? The most obvious answer is the countries’
greater needs for transplants for HIV-positive individuals given large
populations of HIV-infected citizens. But this answer does not seem
correct. Approximately twenty percent of South Africa’s population
is infected with HIV.51 While one may think the incidence of HIV is
much less in the United States, as previously noted, the CDC
estimates that 1.2 million people aged thirteen years and older are
living with HIV, including over 156,300 who are unaware they are
affected.52
A more appropriate reason for the United States’ slow response to
HIV-positive transplants may lie in the unknown risks of such
transplants. Of particular concern is “‘superinfecting’ a HIV-positive
patient with a . . . strain of the virus” from the donated organ. 53 Also,
it remains unclear as to how antiretroviral drugs will interact with
anti-rejection drugs taken by transplant patients.54 There are concerns
that immunosuppressive drugs55 that prevent organ rejection would
worsen HIV progression, for such drugs weaken one’s immune
system, which is already compromised in an HIV-patient.56 There is
also a fear of mislabeling an HIV-infected organ, which might result
in transplantation into an HIV-negative patient.57 Even Dr. Muller
highlights a continued need for research to perfect the safety of
positive-to-positive transplants.58 It is for these reasons that the new
law has ongoing research and review standards.59 But, “[r]ecent
studies have shown that transplant outcomes in selected HIV-positive

50.
51.
52.
53.
54.
55.

56.
57.
58.
59.

Id.
Reardon, supra note 46.
HIV in the United States, supra note 18.
Reardon, supra note 46.
Id.
Immunosuppressant drugs suppress the body’s immune system to lower the body’s
ability to reject a transplanted organ by decreasing the body’s reaction to the foreign
organ. Anna Giorgi, Immunosuppressant Drugs, HEALTHLINE (June 20, 2013),
http://www.healthline.com/health/immunosuppressant-drugs#Overview1.
Liver Transplant, NAM AIDSMAP, http://mobile.aidsmap.com/Livertransplant/page/1731924 (last visited Nov. 13, 2015).
Ending HIV Organ Donation Ban, supra note 31.
Reardon, supra note 46.
42 U.S.C. § 274f-5 (Supp. I 2013).
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people can be nearly as good as those seen in people without HIV.”60
Transplants seem most successful in patients with well-controlled
HIV, and some patients are able to tolerate antiretroviral drugs after
receiving a liver transplant.61
C. Current Legislation’s Likely Consequences
The current legislation dealing with the new transplant policy in the
United States is not very extensive. It reads as follows:
(a) In general:
Not later than 2 years after November 21, 2013, the
Secretary shall develop and publish criteria for the
conduct of research relating to transplantation of organs
from donors infected with human immunodeficiency
virus (in this section referred to as “HIV”) into
individuals who are infected with HIV before receiving
such organ.
(b) Corresponding changes to standards and regulations
applicable to research:
Not later than 2 years after November 21, 2013, to the
extent determined by the Secretary to be necessary to
allow the conduct of research in accordance with the
criteria developed under subsection (a)—
(1) the Organ Procurement and Transplantation
Network shall revise the standards of quality
adopted under section 274(b)(2)(E) of this title;
and
(2) the Secretary shall revise section 121.6 of title
42, Code of Federal Regulations (or any successor
regulations).
(c) Revision of standards and regulations generally:
Not later than 4 years after November 21, 2013, and
annually thereafter, the Secretary, shall—
(1) review the results of scientific research in
conjunction with the Organ Procurement and
60.
61.

Liver Transplant, supra note 56.
Id.
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Transplantation Network to determine whether the
results warrant revision of the standards of quality
adopted under section 274(b)(2)(E) of this title
with respect to donated organs infected with HIV
and with respect to the safety of transplanting an
organ with a particular strain of HIV into a
recipient with a different strain of HIV;
(2) if the Secretary determines under paragraph (1)
that such results warrant revision of the standards
of quality adopted under section 274(b)(2)(E) of
this title with respect to donated organs infected
with HIV and with respect to transplanting an
organ with a particular strain of HIV into a
recipient with a different strain of HIV, direct the
Organ Procurement and Transplantation Network
to revise such standards, consistent with section
274 of this title and in a way that ensures the
changes will not reduce the safety of organ
transplantation . . . .62
While this legislation has been enacted into law, it will most likely
be at least several months before the United States hears of the first
HIV-positive-to-HIV-positive transplant. The current legislation
“directs the Department of Health and Human Services . . . and the
Organ Procurement and Transplant Network . . . to develop standards
[that will] make these transplants possible” by 2015.63 In particular,
by November 2015, the Secretary “shall develop and publish criteria
for the conduct of research relating to transplantation of organs from
donors infected with [HIV] into individuals who are infected with
HIV before receiving such organ.”64 These standards are to be
updated and reviewed no later than four years after November 21,
2013, and annually thereafter in order to accommodate current
scientific research.65
The result of the HOPE Act may be more transplants for HIVpositive individuals and thus more lives saved. In a recent case
alleging negligence in an HIV-infected organ transplant, a doctor
noted that “a patient who received a kidney from an infected donor
would most likely be infected with HIV” and further noted that “a
62.
63.
64.
65.

42 U.S.C. § 274f-5 (footnote omitted).
Krans, supra note 29.
42 U.S.C. § 274f-5.
Id.
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patient who is at the top of the transplant list and likely to receive a
noninfected organ very soon was better off refusing the infected or
possibly infected [organ].”66 Thus, while an HIV-negative recipient
awaits a non-infected organ, the infected organ could be placed in an
HIV-positive individual with no harm resulting to the unaffected
recipient.67 Essentially, individuals partaking in high-risk behaviors
or who are diagnosed as having HIV can still serve a donative
purpose without risking infection to an HIV-negative recipient, and
an uninfected recipient may be more willing to wait for an uninfected
organ knowing that more donations equals less time on the transplant
waiting list. It is too soon to back up this idealistic outcome with
empirical evidence, but perhaps this could be one good consequence
that results from the new HOPE Act.
II. CHANGING THE STANDARD TO ALLOW FOR
TRANSPLANTS AFTER CARDIAC DEATH
Once an individual is declared brain dead, organ donation may
occur;68 however, changing this standard to allow for organ donation
when cardiac death is irreversible may, in fact, increase the amount
of available organs to be donated.
A.The Current Transplant Standard: Brain-Death
It is universally accepted that an individual is deceased when his or
her brain no longer has activity.69
Nevertheless, mechanical
ventilators and other medical techniques can continue to allow the
heart to beat and the blood to circulate for a prolonged period of
time.70 The current standard at which time a doctor may consider an
individual for organ donation is at the point of brain death. 71 When a
patient is no longer responsive, a physician, usually a neurosurgeon
or neurologist, performs a series of tests to determine if brain death
has occurred.72 Patients are declared brain dead when there is no
brain activity and when the patient cannot breathe on his own, for
66.
67.
68.

69.
70.
71.
72.

Doe v. Univ. of Chi. Med. Ctr., 20 N.E.3d 1, 10 (Ill. App. Ct. 2014).
Id.
Ajay Kumar Goila & Mridula Pawar, The Diagnosis of Brain Death, 13 INDIAN J.
CRITICAL CARE MED. 7, 7 (2009), http://www.ijccm.org/temp/IJCCM13173497178_094251.pdf.
Id.
Id. at 7–8.
Id. at 7.
U.S. Dep’t of Health and Human Servs., Organ Donation: The Process,
ORGANDONOR.GOV, http://www.organdonor.gov/about/organdonationprocess.html#pro
cess3 (last visited Nov. 13, 2015).
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these symptoms are irreversible.73 Brain death occurs in less than one
percent of all deaths in the United States.74 Such patients usually
“suffer an injury to the brain resulting from a trauma, stroke or lack
of oxygen.”75
After an individual is declared brain dead, the hospital notifies its
local organ procurement organization and gives the organization
information about the patient to confirm whether he is a candidate for
donation.76 If the deceased has enrolled as a donor, then this
enrollment serves as consent, but if not, consent must be received
from the next of kin.77 But what if the declaration of death relied on a
different standard, one that could possibly start the transplant process
well before brain death occurs? Enter the consideration of donation
after cardiac death.
B. A Proposed New Standard of Donation After Cardiac-Death
and Its Implications
Cardiac death is different than brain death. Sudden cardiac death is
an unexpected death caused by loss of heart function.78 “It is
triggered by an electrical malfunction in the heart that causes an
irregular heartbeat[,]” and patients must receive treatment within
minutes or they will die.79 While sudden cardiac death is reversible
in most victims if treated immediately,80 it is “the largest cause of
natural death in the United States, causing about 325,000 adult deaths
. . . each year.”81 This condition is different than a heart attack. “A
heart attack occurs when a blocked artery prevents oxygen-rich blood
from reaching a section of the heart.”82 If the artery is not opened,

73.
74.
75.
76.
77.
78.

79.

80.
81.
82.

Id.
Understanding Death Before Donation, GIFT OF A LIFETIME,
http://www.organtransplants.org/understanding/death/ (last visited Nov. 13, 2015).
Id.
Organ Donation: The Process, supra note 72.
Id.
Sudden Cardiac Death, CLEV. CLINIC,
http://my.clevelandclinic.org/services/heart/disorders/arrhythmia/scd (last visited Nov.
13, 2015) [hereinafter CLEV. CLINIC].
Heart Attack or Sudden Cardiac Arrest, AM. HEART ASS’N,
http://www.heart.org/HEARTORG/Conditions/More/MyHeartandStrokeNews/HeartAttack-or-Sudden-Cardiac-Arrest-How-Are-TheyDifferent_UCM_440804_Article.jsp (last updated Aug. 19, 2015).
Id.
CLEV. CLINIC, supra note 78; Heart Attack or Sudden Cardiac Arrest, supra note 79.
Heart Attack or Sudden Cardiac Arrest, supra note 79.
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the part of the heart fed by that artery begins to die; thus, the longer a
patient is without treatment, the more damage is done to the heart.83
“Donor after cardiac death (DCD) means an individual who
donates after his or her heart has irreversibly stopped beating. A
donor after cardiac death may be termed a non-heartbeating or
asystolic donor.”84 No specific statutory authorization of DCD exists
in federal law; instead, DCD relies on “existing statutory framework
governing the planned withdrawal of life supportive measures in
terminally ill patients, the ability of those patients or their families to
make an anatomical gift, and the pronouncement of death in those
patients by cardiopulmonary criteria.”85 Thus, the process for DCD
starts when life-supportive measures are withdrawn from a terminally
ill patient either by consent of the family or an advanced directive of
the patient.86
The use of DCD organs is fairly routine in many European
countries as well as South America, Australia, and Japan.87
Specifically, there are five categories of DCD donors: two categories
for donors who die unexpectedly and three categories for donors
whose death is anticipated.88
However, different legislations
regarding consent for organ donation and different attitudes
concerning the withdrawal of futile life-sustaining treatments make
DCD a controversial topic.89 Of course, the existence of consent,
either by the donor or by a family representative, is mandatory and
can have ethical and legal implications of its own. Grieving family
members may argue that a donor’s consent for organ donation meant
consent to donation after brain death, not cardiac death. 90
Furthermore, finding a family member authorized to make end-of-life
decisions in the absence of a patient directive is legally required and
83.
84.
85.

86.
87.

88.
89.
90.

Id.
42 C.F.R. § 486.302 (2014).
Frederick J. White III & J. Kelly Elrod, Institutional Ethics & Comm. of the WillisKnighton Health Sys., Organ Donation After Cardiac Death: A Louisiana Hospital
Ethics Committee Perspective, 39 S.U. L. REV. 71, 85 (2011).
Id. at 86 & n.58.
Umberto Maggiore et al., Strategies to Increase the Donor Pool and Access to Kidney
Transplantation: An International Perspective, 30 NEPHROLOGY DIALYSIS
TRANSPLANTATION 217, 221 (2015), http://ndt.oxfordjournals.org/content/30/2/217.ful
l.pdf+html?sid=3ce37119-b5e8-40b5-b9ff-e31baa83cd1e.
Id.
Id.
Bernadette Richards & Wendy A. Rogers, Organ Donation After Cardiac Death:
Legal and Ethical Justifications for Antemortem Interventions, 187 MED. J. AUSTL.
168, 168 (2007), https://www.mja.com.au/system/files/issues/187_03_060807/ric1016
6_fm.pdf.
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thus may prove difficult for individuals without immediate family
present.91 Of particular concern to doctors is the ethical conflict
between DCD donations, when an individual is not considered brain
dead, and the Hippocratic Oath of “do no harm.”92 Does the invasive
removal of organs from a patient who is not declared brain dead harm
the patient and thus conflict with a doctor’s ethical oath?
Several concerns surround a doctor’s implementation of DCD,
First, interventions
especially in controlled DCD patients.93
administered ante-mortem to preserve the organs of a potential donor
can cause harm and thus infringes on a doctor’s ethical oath to do no
harm and to act only in the interest of the patient.94 DCD supporters
respond by stating that ante-mortem intervention is not proven to
cause harm to the patient.95 Others cite the doctrine of double effect
from medical ethics. According to this doctrine,
[A]n action that has both good and bad effects, such as
administering morphine to a terminally ill patient, which can
both relieve pain and hasten death, may be permissible if
four conditions are met: 1) the act is not itself immoral—it
may be good, but is at least indifferent; 2) the intent in
performing the act is only the good effect, although the bad
effect may be foreseen; 3) the bad effect must not be a
means to the good effect; and 4) the act is performed for an
adequately serious reason.96
Thus, ante-mortem interventions would seem to meet these
conditions and be ethically permissible.97
In uncontrolled DCD patients, those who have already suffered
cardiac arrest and failed resuscitative measures, this ethical
conundrum is less concerning.98 However, other concerns emerge in
these instances. Since other, more aggressive techniques can be used
to resuscitate an individual, labeling an uncontrolled DCD patient’s
91.
92.
93.

94.
95.
96.
97.
98.

Id. at 169.
Id. at 168.
Controlled DCD occurs in those patients whose heart has not necessarily suffered
cardiac arrest or sustained failed resuscitative measures. Jeremy R. Simon et. al.,
Donation After Cardiac Death and the Emergency Department: Ethical Issues, 21
ACAD. EMERGENCY MED. 79, 80–81 (2014).
Id.
Id. at 81.
Id.
Id.
Id. at 82.
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heart as irreversibly dead can be tricky.99 Technological advances,
such as extracorporeal membrane oxygenation (ECMO)100 make the
phrase “irreversible cessation of circulatory and respiratory
function[s]” difficult to understand.101 Applying a strict interpretation
to this phrase, ECMO patients would technically not be seen as dead
since they would have circulation of oxygenated blood.102 Thus,
removing an ECMO patient from this device for purposes of organ
harvesting could open doctors up to criminal liability since the patient
would technically not be seen as dead.103 Furthermore, there may be
a concern that doctors will not try as hard to resuscitate uncontrolled
DCD patients, hoping their organs will be of value to eager
recipients.104 These ethical considerations make the concept of DCD,
both controlled and uncontrolled, controversial in the medical world.
Even more disconcerting for both medical ethicists and the legal
community is the term “irreversible death” utilized for purposes of
DCD. Legally, the concept of uncontrolled versus controlled DCD
poses problems. In particular, “nearly every state . . . has adopted” a
form of the Uniform Determination of Death Act (UDDA), which
“outlines the two means by which death can be determined for organ
transplantation.”105 However, the UDDA does not address “how long
cardiac and respiratory functions must have ceased before they can be
considered irreversible,” and thus variations in determinations of
death occur.106 This conundrum leaves the doctor in a precarious
position between waiting long enough to declare cardiac death
irreversible and not waiting too long to render organs unviable.107

99. Id.
100. “Extracorporeal membrane oxygenation (ECMO) is a treatment that uses a pump to
circulate blood through an artificial lung back into the bloodstream . . . .” U.S. Nat’l
Library of Med., U.S. Dep’t of Health and Human Servs., Extracorporeal Membrane
Oxygenation, MEDLINEPLUS, http://www.nlm.nih.gov/medlineplus/ency/article/00723
4.htm (last updated Nov. 2, 2015).
101. Abel, supra note 4, at 600 (quoting Robert M. Veatch, Donating Hearts After Cardiac
Death—Reversing the Irreversible, 359 NEW ENG. J. MED. 672, 672 (2008)); accord
UNIF. DETERMINATION OF DEATH ACT § 1 (NAT’L CONFERENCE OF COMM’R ON UNIF.
STATE LAWS 1980).
102. Abel, supra note 4, at 603.
103. Id.
104. Simon et al., supra note 93, at 82.
105. Abel, supra note 4, at 600.
106. Id.
107. Id. at 600–01.
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C. How Changing the Standard May Increase Available Organs
In the United States, DCD donors consist of only about ten percent
of organ donations.108 Considering the greater number of cardiac
deaths than brain deaths that occur each year, perhaps making cardiac
death versus brain death the standard to start the organ donation
process would result in more organs to donate. A consultant for The
New England Journal of Medicine made this startling claim in 2007,
stating this theory “has been demonstrated at organ banks in
Wisconsin, the Boston metropolitan region and the Finger Lakes
region of New York . . . where cardiac death donors account for more
than 20 percent of all deceased donors.”109 Such donors included
“patients on ventilators after devastating and irreversible brain
injuries, as might follow a hemorrhagic stroke, as well as patients
with high spinal cord injuries and terminal musculoskeletal diseases
like ALS, for whom further medical treatment is deemed futile.”110
Under the brain-death standard for organ donation, these patients are
technically not dead for the purpose of organ harvesting. 111 However,
if these patients were considered suitable donors under a DCD organ
donation standard, life-support measures could be ended and their
organs successfully harvested.112
Currently, DCD only becomes a viable alternative for those who
have previously consented to the removal of life support or whose
family has done so.113 Ultimately, the harvesting of organs from
cardiac death patients should not be looked at as a way to sidestep the
criteria for brain death but as a way to afford donors or their families
“donation that complies with patient or authorized family
directives.”114

108. Maggiore et al., supra note 87.
109. See Jane Brody, The Solvable Problem of Organ Shortages, N.Y. TIMES (Aug. 28,
2007), http://www.nytimes.com/2007/08/28/health/28brod.html?_r=1&.
110. Id.
111. Id.
112. Id. “DCD has evolved into routine clinical practice that currently supplies >10% of
all deceased-donor kidneys in the United States . . . .” Maarten G. Snoeijs et al.,
Kidneys from Donors After Cardiac Death Provide Survival Benefit, 21 J. AM. SOC’Y
NEPHROLOGY 1015, 1016 (2010), http://jasn.asnjournals.org/content/21/6/1015.full.pd
f+html.
113. Donation After Cardiac Death (DCD), LIFEPOINT, INC., http://www.lifepointsc.org/facts_cardiac.htm (last visited Nov. 13, 2015).
114. Id.
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III. EDUCATING INDIVIDUALS, ESPECIALLY MINORITIES,
ABOUT DONATION
It is alleged that “the organ transplant system operates with a builtin bias against the poor,” making minorities “nearly half as likely to
receive organs,” despite their greater demand.115 This disparity may
be linked to disparate education about organ donation. There have
been many studies indicating that, for both minority and majority
groups, education leads to a greater possibility of organ donation.116
A. A Greater Minority Need for Transplants
The need for transplants in some minority groups is
disproportionately high as a result of a higher incidence of medical
conditions for particular minorities.117 The U.S. Department of
Health and Human Services explains that “African Americans,
Asians and Pacific Islanders, and Hispanics/Latinos are three times
more likely than Caucasians to suffer from end-stage renal (kidney)
disease, . . . . [and] [a]lmost 34 percent of the more than 101,000
people on the national waiting list for a kidney transplant are African
American.”118 Further, “African Americans make up 12% of the
region’s overall population, but represent 43% percent of patients on
the kidney transplant waiting list.”119 Similarly, Hispanics are in the
same position, being three times more likely than Caucasians to
suffer from a disease requiring a kidney transplant.120
While “organs are not matched according to [one’s] race[,] . . . all
individuals waiting for an organ transplant will have a better chance
of receiving one if there are large numbers of donors from their
racial/ethnic background.”121 This is due to the fact that individuals
of similar ethnicity are more likely to be of compatible blood types

115. Kristen Gwynne, How the Organ Transplant System Is Stacked Against the Most
Needy, and Why You Should Be a Donor, ALTERNET (Aug. 19, 2011), http://www.alte
rnet.org/story/152074/how_the_organ_transplant_system_is_stacked_against_the_mo
st_needy,_and_why_you_should_be_a_donor.
116. See id.
117. U.S. Dep’t of Health and Human Servs., Why Minority Donors Are Needed,
ORGANDONOR.GOV, http://organdonor.gov/whydonate/minorities.html (last visited
Nov. 13, 2015).
118. Id.
119. Multicultural Donation Statistics, GIFT OF LIFE DONOR PROGRAM,
http://www.donors1.org/learn2/multicultural/statistics/ (last visited Nov. 13, 2015).
This region includes Delaware, the eastern half of Pennsylvania, and southern New
Jersey. Id.
120. Id.
121. Why Minority Donors Are Needed, supra note 117.
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and tissue markers.122
For example, “the African-American
population has a high prevalence of type B blood, which is more rare
in the general population.”123 The lack of compatible donors may
explain why it generally takes longer for an African American to
obtain a lifesaving organ.124
B. Education May Encourage Donation and May Get Recipients on
More Transplant Lists
While African Americans constitute about 13% of organ donors in
total,125 thirty percent of individuals currently waiting for an organ
donation are African American.126 If more minorities, particularly
African Americans, were educated about donations and encouraged
to donate, perhaps the greater likelihood of organ matches would
equal more successful transplants and thus fewer individuals on the
transplant list. Education can begin by making the steps for signing
up as a donor more apparent. Different states have different
processes for enrollment, with some allowing enrollment through the
DMV while others require online enrollment.127 While this may not
seem confusing for some, educating individuals, specifically those
without access to quality health care, as to how to donate and about
the importance of donation, may increase their likelihood of
donation. Furthermore, expending resources to educate living donors
about the greater need for organs may increase donation and result in
large savings in healthcare expenditures.128
In addition, education about the regional based system may
encourage more possible recipients to place their names on multiple
regional lists, resulting in a greater chance of receiving an organ.
Currently, the country is divided into eleven allocation regions, with
each region having its own organ procurement organization to

122.
123.
124.
125.
126.

Id.
See Gwynne, supra note 115.
Id.
Id.
U.S. Dep’t of Health and Human Servs., African Americans and Organ Donation,
ORGANDONOR.GOV, http://organdonor.gov/minortyaa/index.html (last visited Nov. 13,
2015).
127. See Gwynne, supra note 115.
128. A kidney from a living donor is often superior to one from a deceased donor since it
lasts almost twice as long. Harvey Mysel, How to Increase the Number of Kidney
Transplants, LIVING KIDNEY DONORS NETWORK, http://www.lkdn.org/how_do_we_in
crease_article.pdf (last visited Nov. 13, 2015). Furthermore, recent studies reveal that
removing someone from kidney dialysis “saves a present value of $1 million.” Id.
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“oversee[] the selection of organ transplant patients.”129 Because of
the disparate populations of the regions, “[s]ome regions have more
donors or transplant centers than others, making the regional list
lengths unequal.”130 Organs are allocated regionally to the sickest,
best-matched patients; however, if a region has no viable matches,
the organ moves to a nearby location, applying the same matching
criteria.131 Individual recipients may put their name on multiple
waiting lists, especially on regional lists of neighboring states, to
have a better chance of finding a donor match.132 Karen Cummings, a
specialist at the New York Organ Donation Network, states that the
issue for many individuals, especially minorities, “is making sure
they know that, for example, Pennsylvania, Connecticut, those are
areas in your region.”133 Similarly, leading experts in the field agree
that “community empowerment, education and encouraging
communities to discuss wishes upon death are key to increasing
organ transplantation in any community.”134
But education does not just promote organ donations for donors;
educating doctors also encourages organ donations in general.
Education for doctors includes programs that teach care-givers how
to broach the topic with a more sensitive approach and working in a
team to lend support to the family faced with the decision.135 Most
recently, “[t]hrough partnerships with local organ procurement
organizations, medical schools and teaching hospitals are educating
residents, fellows, and other members of their medical staffs not only
in better communication with families during difficult times but also
in ways to introduce families to organ procurement
representatives.”136 While success of education programs may be
hard to quantify, the Association of Organ Procurement Organization
has noted that “a determined focus on opportunities for organ
donation has worked in the past to improve education and
understanding.”137 For example, in 2003, the U.S. Department of
129.
130.
131.
132.
133.
134.
135.

See Gwynne, supra note 115.
Id.
Id.
Id.
Id.
Id.
See Jennifer Anderson, Increasing Organ Donation Through Education, REPORTER
(ASS’N OF AM. MED. COLLS., D.C.), July/Aug. 2014, https://www.aamc.org/newsroo
m/reporter/julyaugust2014/401414/organ-donation.html (“[R]esidents and other
medical staff are taught, through role playing and other techniques, how to share bad
news with families.”).
136. Id.
137. Id.
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Health and Human Services, through its national Donation and
Transplantation Collaborative, worked to educate families and care
providers and, as a result, donation rates increased from 50% to
75%.138 While donation rates have plateaued since this initiative,139
other regions have proven that education is still a means by which to
increase organ donation. At Johns Hopkins Hospital, end-of-life
education increased donations from 44% in 2002 to 80% in 2014.140
IV. OTHER POSSIBLE SOLUTIONS: PAYMENTS,
ADVERTISING, PRIORITY LISTS, AND CHANGING AGE
REQUIREMENTS
While the HOPE Act, education programs for both donors and
recipients, and a change in donation standards are the most widely
discussed ways in which the number of available organs can be
increased, there are other, less talked about, means by which the
supply of organs can be increased.
Setting aside ethical
considerations, individuals have proposed paying and advertising for
organ donations, as well as giving priority on transplant lists to those
patients who are organ donors.141 In addition, there is a disparity
between the number of elderly donors and the rate at which these
harvested organ are transplanted.142 Perhaps with the implementation
of new requirements in 2014, this disparity will be lessened, resulting
in a larger number of transplantable organs.
A. Payments, Solicitations, and Priority Status
In a 2011 research study conducted by the University of
Pennsylvania, professors tested whether organ donation would
increase if transplant waiting list priority was given to registered
organ donors.143 “The underlying economic rationale . . . is that by
providing priority on the waiting list, you are giving an incentive to
register as a donor.”144 In order to test their theory, the professors set
up a gaming system to judge whether priority registration would lead

138.
139.
140.
141.

Id.
Id.
Id.
Wharton Sch., Univ. of Pa., How to Encourage People to Become Organ Donors,
KNOWLEDGE@WHARTON (Oct. 7, 2011), http://knowledge.wharton.upenn.edu/article/
how-to-encourage-people-to-become-organ-donors-an-incentive-system-with-heart/.
142. Maggiore et al., supra note 87, at 220.
143. Wharton Sch., Univ. of Pa., supra note 141.
144. Id. (quoting Judd Kessler, Bus. & Pub. Policy Professor, Wharton Sch., Univ. of Pa.).
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to a greater willingness to donate.145 The results overwhelmingly
indicated that individuals were willing to register in order to receive
priority transplants.146 A variation of this incentive program may be
to require individuals who receive an organ to then either give an
organ in return or to register as an organ donor.147 Likewise, some
believe an “opt-out” provision, one in which individuals are
automatically registered as donors and must actively opt out of this
choice, may increase organ donation.148
The University of Pennsylvania researchers also broached another
controversial means by which organ donations may increase. They
gave either a discount or a rebate for agreeing to donate, providing a
monetary incentive to register as a donor.149 “[T]hese monetary
incentives worked just as well as giving [waiting-list] priority to
donors,”150 and thus providing financial incentive could increase the
availability of transplantable organs.151 The receipt of a benefit for a
donation, especially for living donors, makes sense. Living donor
donations are rare because, unlike a deceased donor, a living donor
must make a personal sacrifice, bearing any health risks associated
with the donation.152 Thus, by requiring an incentive such as priority
receipt of an organ or monetary compensation,153 more living donors
may be willing to donate.
145. Id.
146. Id. (“[W]illingness to pay the cost of donation shot up to over 100%, to between 70%
and 80% of subjects registering to donate.”).
147. Denise Aptekar, Comment to How Can Organ Donations Rated Be Improved?,
QUORA, http://www.quora.com/How-can-organ-donation-rates-be-improved (last
updated Feb. 7, 2013).
148. Id. New York and California have unsuccessfully attempted to pass presumed
consent laws in which every person, upon death, is considered a donor unless he has
opted out of donation. Mysel, supra note 128.
149. Wharton Sch., Univ. of Pa., supra note 141.
150. Id. It is important to note that any proposal for compensating donors is met with
extreme opposition by medical ethicists. Mysel, supra note 128.
151. Kristy Lynn Williams et al., Just Say No to NOTA: Why the Prohibition of
Compensation for Human Transplant Organs in NOTA Should Be Repealed and a
Regulated Market for Cadaver Organs Instituted, 40 AM. J.L. & MED. 275, 302
(2014) (“Offering monetary compensation for organs will likely increase the number
of organ donors in the United States and thus narrow the gap between the number of
organs needed and the number of organs available.”).
152. Alexandra K. Glazier & Scott Sasjack, Should It Be Illicit to Solicit? A Legal Analysis
of Policy Options to Regulate Solicitation of Organs for Transplant, 17 HEALTH
MATRIX 63, 72 (2007).
153. Compensation in the form of travel and lodging, government-paid life insurance in the
event of death during donation, payments for college tuition and tax credits have also
been suggested along with monetary compensation. Editorial, Ways to Reduce the
Kidney Shortage, N.Y. TIMES (Sept. 1, 2014), http://www.nytimes.com/2014/09/02/op
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The concept of payment for or solicitations of donations is ethically
controversial.154 Currently, there is a federal prohibition on the sale
of human organs for transplantation by the National Organ
Transplant Act (NOTA).155 However, arguments in favor of financial
incentives state that such a system “would increase the supply of
organs and thereby secure the basic ethical concern of saving lives
that may otherwise be lost due to the lack of this resource.” 156
Furthermore, the medical care system could benefit: assuming 500
additional live donors opted to donate organs for money, a $30
million savings could result, allowing for other transplant-related
programs.157 On the other hand, there are compelling arguments
against financial incentives. Opponents of such financial incentives
“point out that there would be potentially decreased emotional gain
for the donor family, decreased respect for life and the sanctity of the
human body, and a loss of the personal link that currently exists in
the donation process.”158 There are also concerns about the impact
such compensation may have on the economically disadvantaged
population willing to sell their kidneys for cash.159 Thus, methods by

154.

155.

156.

157.
158.
159.

inion/ways-to-reduce-the-kidney-shortage.html?_r=1. The National Organ Transplant
Act, discussed supra Part I.B., “permits reimbursement for ‘the expenses of travel,
housing, and lost wages incurred by the donor of a human organ in connection with
the donation of the organ.’” Williams et al., supra note 151 at 300 (quoting 42 U.S.C.
§ 274e(c)(2) (2012)). Furthermore, income tax benefits for organ donors is currently
permitted in seventeen states. Id.; see also § 274e(c)(2).
Williams et al., supra note 151, at 287. The shortage of organs has caused some to
call for the establishment of a commercial market for organs in which the donor sells
an organ for a fee. This market system is not a legal market in the United States, even
though illegal black markets in human organs exist. Interestingly, the National Organ
Transplantation Act’s prohibition on the sale of human organs is only restricted to
transplants, thus, allowing the sale of organs and body parts for other purposes. Id.
Id. This prohibition only applies to transplantation, so the sale of organs and body
parts for other purposes is allowed. NOTA prohibits “the creation of a national
regulated market for organs, but it also potentially prohibits states from providing any
financial incentives to living donors and the estates of cadaver donors.” Id. at 292.
PAYMENT SUBCOMM., U.S. DEP’T OF HEALTH AND HUMAN SERVS., FINANCIAL
INCENTIVES FOR ORGAN DONATION (1993), http://optn.transplant.hrsa.gov/resources/et
hics/financial-incentives-for-organ-donation/.
Id.
Id.
A further concern regarding the underprivileged who receive transplants is the
expense of antirejection drugs. Many of these individuals cannot afford to pay for the
antirejection drugs, which can cost more than $1000 a month. Medicare stops paying
for these drugs after three years, unless the patient is old and disabled. As such,
Congress’ extension of Medicare coverage for antirejection drugs may increase the
success of transplants and thus lessen the number of individuals who make their way
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which such concerns could be ameliorated have been proposed,
including “limiting payments to sales of cadaver organs, limiting the
compensation that may be paid for each organ, regulating the
exchange such that compensation is paid by a third party government
agency and not directly from recipient to donor, and setting donor
health standards.”160
There are also differing views as to how the sale of organs is
connected or related to property rights.161 “One view is that the sale
of organs is impossible because the body is not property in a
commercial sense.”162 A second view does not object to the sale of
organs but objects to the commodification of the body. 163 A final
view recognizes that commercial activity occurs with the “trading” of
body parts and instead questions whether compensation for donated
organs should be paid to the donor or donor’s estate.164 These various
views concerning organs as property further complicate the already
controversial ethical debate surrounding the sale of organs.
A similar ethical debate also surrounds the solicitation of organs.
A growing number of individuals, labeled “transplant tourists,” have
begun to travel in order to find a transplantable organ in a donor
country.165 Similarly, others have begun to travel the web to find a

160.
161.

162.
163.
164.
165.

back on to the transplant list. Ways to Reduce the Kidney Shortage, supra note 153.
While this remains a concern for some, others have contemplated safeguards that
would guard against this, such as regulating an upper limit on the amount of
compensation that can be given for a donation, limiting the market to cadaver organs
to protect living donors, and requiring extensive health checks of potential living
donors to eliminate the risk of future complications. Williams, supra note 151, at
309–10.
Williams, supra note 151, at 302.
While the common law in the United States recognized a quasi-property interest in the
body, statutory law in the form of the Uniform Anatomical Gift Act of 1968 impacted
this common law in several ways:
(1) [P]roviding general guidelines for the post mortem donation of
body parts; (2) providing priority of the decedent’s wishes on
organ donation over that of their next of kin; (3) prohibiting the
sale of specific organs; and (4) impacting the laws on whether
coroners or medical examiners can make gifts of bodies in their
possession.
Id. at 281–83 (footnotes omitted).
Id. at 280.
Id.
Id.
Transplant tourism has its own fans and critics. Some cite the advantages as being a
potential savings in cost and the matching of donors and recipients who otherwise
would not have met. Negatively, critics state that transplant tourism may pose health
and safety risks as individuals travel to foreign countries with different health laws
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transplant, using websites such as MatchingDonors.com.166 The
process at matching donor websites is described as follows:
[P]otential recipients pay a membership fee to post their photos and
personal stories describing their transplant organ needs. Potential
donors pay no fee and are able to browse the profiles of over 4,000
potential recipients. If a potential donor is interested in a potential
recipient, the potential donor can contact the potential recipient to
begin a dialogue and, if both agree, to proceed with the organ
donation process.167
Proponents for internet solicitation claim that a valuable service
allows altruistic potential donors to find needy patients in a safe
manner.168 Furthermore, other safeguards prevent coercion, such as
the psychological screening procedures for live donors implemented
at many hospitals.169 Other medical facilities may refuse to perform
transplants on individuals who met through an internet site. 170
Legally, internet solicitation is allowed under § 6(A)(3) of the 1987
version of the Uniform Anatomical Gift Act, which “permits directed
organ donation for transplantation purposes” without regard to how
the recipient or donor met.171
Opponents of internet solicitation claim that such sites help
circumvent the law as willing donors are paid under the table for
organs by recipients.172 Furthermore, critics claim that, by bypassing
transplant wait lists, soliciting recipients weaken the formal
transplant wait list structure and allow for a disorganized allocation
of organs.173 Critics also cite the superficiality of internet solicitation,
claiming individuals may select recipients on criteria such as beauty
or race.174 Finally, there is concern about the veracity of potential

166.
167.
168.
169.
170.
171.

172.
173.
174.

and regulations. Liliana M. Kalogjera, New Means of Increasing the Transplant
Organ Supply Ethical and Legal Issues, HUM. RTS. 19, 21–22 (2007).
Id. at 21.
Id.
Id.
Id. at 22.
Id.
Id.; see also UNIF. ANATOMICAL GIFT ACT § 6(A)(3) (NAT’L CONF. OF COMM’RS ON
UNIF. STATE LAWS 1987) (directing that a “designated individual” may become a
donee of anatomical gifts for the purpose of “transplantation or therapy needed by that
individual”).
Kalogjera, supra note 165, at 22.
Id.
Id.
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recipients’ profiles due to the lack of legal safeguards regulating such
websites.175
B. Ending Age-Restrictions on Donations and Receipt
Up until the 1990s, donor organs from individuals over fifty-five
were rarely used since organs donated from older individuals resulted
in reduced graft function and reduced recipient and graft survival. 176
However, age matching between donor and recipient has been
adopted by most European countries,177 and the United States is now
catching on to the trend. In the United States, despite the use of
kidneys from donors older than sixty, the percentage of organs that
are harvested from this population yet not transplanted is 40%.178
The major reasons that these organs are discarded are unfavorable
biopsy findings.179 However, a new change may mean greater use for
these once discarded organs. The United Network of Organ Sharing
Kidney Transplantation Committee approved and implemented a
policy in 2014 that may result in fewer discarded organs. 180 The new
policy is based on the Kidney Donor Profile Index (KDPI), a measure
of donor quality, that is an improvement of the older standards.181
“KDPI is a percentile rank, based on a number of donor risk
indicators (KDPI = 85 means that 85% of donors are of better
quality).”182 Transplant programs can accept different quality
kidneys and match kidneys according to the recipient’s age and
medical circumstances “by establishing candidate-specific KDPI
acceptability thresholds.”183
A program such as this has already experienced success in
European countries. In 1999, the Eurotransplant foundation initiated
the Eurotransplant Senior Programme (ESP).184 Under the program,
donor kidneys that are older than sixty-five are matched to recipients
older than sixty-five to allow the most use of such marginal organs
and to reduce wait times for elderly individuals.185 Survival rates of
ESP program participants have proven similar to those of elderly
175.
176.
177.
178.
179.
180.
181.
182.
183.
184.
185.

Id.
Maggiore et al., supra note 87, at 220.
Id.
Id.
Id.
Id.
Id.
Id.
Id.
Id. at 220–21.
Id.
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recipients receiving a younger graft.186 Other European countries are
even more adventurous. In Italy, for example, donor kidneys that are
older than sixty-five can be given to younger recipients.187
In the United States, the problem of discarded organs may not only
be attributable to the age of a person but also to the age of an organ.
Many organs taken from deceased donors are discarded every year
since transplantation does not occur within the twenty-four to thirtysix hour window from recovery to evaluation to transplant.188 Some
experts estimate that approximately 1,000 organs are discarded each
year because the time runs out before a suitable donor is found. 189
The United Network for Organ Sharing was expected to change its
formulas in December 2014 to increase the utilization of donated
kidneys and to reduce waste.190 As such, by finding a viable use for
once discarded donations, especially those from elderly patients and
“stale” organs, doctors may increase the supply of transplantable
organs.191
V. CONCLUSION
There are thousands of people on the transplant list, and this
number grows every day. By increasing the supply of available
186.
187.
188.
189.
190.
191.

Id. at 221.
Id.
Ways to Reduce the Kidney Shortage, supra note 153.
Id.
Id.
The elderly are not the only group subjected to discriminatory practices. Those with
physical and mental disabilities also have a difficult time in obtaining transplants.
This has resulted in at least one state passing legislation to prohibit this practice. New
Jersey enacted a law that notes:
Individuals with mental and physical disabilities have been denied
life-saving organ transplants based on assumptions that their lives
are less worthy, that they are incapable of complying with
complex post-transplant medical regimens, or that they lack
adequate support systems to ensure such compliance;
. . . Although organ transplant centers must consider medical and
psychosocial criteria when determining if a patient is suitable to
receive an organ transplant, transplant centers that participate in
the Medicare and Medicaid programs are required to use patient
selection criteria that result in a fair and non-discriminatory
distribution of organs; and
. . . New Jersey residents in need of organ transplants are entitled
to assurances that they will not encounter discrimination on the
basis of a disability.
N.J. STAT. ANN. § 26:6-86.1(c)–(e) (Supp. 2015).
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organs, more individuals may receive life-saving transplants. The
signing of the recent HOPE Act will hopefully make more organs
available for HIV-positive recipients and thus result in more HIVnegative organs available for HIV-negative individuals. By changing
the standards of organ donation from occurring after irreversible loss
of brain function to irreversible loss of cardiac function, the organ
supply may also increase. While this suggestion has negative legal
and ethical implications, the benefit may outweigh the negatives. In
addition, by educating individuals, especially minorities who have the
greatest need for transplants, about donation and the regionally based
system for transplants, more individuals may donate and also receive
a greater chance of receiving a life-saving organ. Finally, other
measures, such as granting priority status to organ donors, allowing
for the payment or solicitation of organs, and allowing age matching
for donations, might increase the supply of organs available to be
transplanted.

